S&P 500   2,584.59 (-1.60%)
DOW   21,917.16 (-1.84%)
QQQ   190.40 (-0.85%)
AAPL   254.29 (-0.20%)
FB   166.80 (+0.51%)
MSFT   157.71 (-1.57%)
GOOGL   1,161.95 (+1.36%)
AMZN   1,949.72 (-0.72%)
CGC   14.42 (-0.28%)
NVDA   263.60 (-0.75%)
BABA   194.48 (+1.68%)
GE   7.94 (+0.63%)
TSLA   524.00 (+4.36%)
AMD   45.48 (-4.97%)
T   29.15 (-3.57%)
ACB   0.91 (+2.26%)
F   4.83 (-3.98%)
NFLX   375.50 (+1.22%)
BAC   21.23 (-3.68%)
GILD   74.76 (-1.54%)
PRI   88.48 (-2.46%)
DIS   96.60 (-3.21%)
S&P 500   2,584.59 (-1.60%)
DOW   21,917.16 (-1.84%)
QQQ   190.40 (-0.85%)
AAPL   254.29 (-0.20%)
FB   166.80 (+0.51%)
MSFT   157.71 (-1.57%)
GOOGL   1,161.95 (+1.36%)
AMZN   1,949.72 (-0.72%)
CGC   14.42 (-0.28%)
NVDA   263.60 (-0.75%)
BABA   194.48 (+1.68%)
GE   7.94 (+0.63%)
TSLA   524.00 (+4.36%)
AMD   45.48 (-4.97%)
T   29.15 (-3.57%)
ACB   0.91 (+2.26%)
F   4.83 (-3.98%)
NFLX   375.50 (+1.22%)
BAC   21.23 (-3.68%)
GILD   74.76 (-1.54%)
PRI   88.48 (-2.46%)
DIS   96.60 (-3.21%)
S&P 500   2,584.59 (-1.60%)
DOW   21,917.16 (-1.84%)
QQQ   190.40 (-0.85%)
AAPL   254.29 (-0.20%)
FB   166.80 (+0.51%)
MSFT   157.71 (-1.57%)
GOOGL   1,161.95 (+1.36%)
AMZN   1,949.72 (-0.72%)
CGC   14.42 (-0.28%)
NVDA   263.60 (-0.75%)
BABA   194.48 (+1.68%)
GE   7.94 (+0.63%)
TSLA   524.00 (+4.36%)
AMD   45.48 (-4.97%)
T   29.15 (-3.57%)
ACB   0.91 (+2.26%)
F   4.83 (-3.98%)
NFLX   375.50 (+1.22%)
BAC   21.23 (-3.68%)
GILD   74.76 (-1.54%)
PRI   88.48 (-2.46%)
DIS   96.60 (-3.21%)
S&P 500   2,584.59 (-1.60%)
DOW   21,917.16 (-1.84%)
QQQ   190.40 (-0.85%)
AAPL   254.29 (-0.20%)
FB   166.80 (+0.51%)
MSFT   157.71 (-1.57%)
GOOGL   1,161.95 (+1.36%)
AMZN   1,949.72 (-0.72%)
CGC   14.42 (-0.28%)
NVDA   263.60 (-0.75%)
BABA   194.48 (+1.68%)
GE   7.94 (+0.63%)
TSLA   524.00 (+4.36%)
AMD   45.48 (-4.97%)
T   29.15 (-3.57%)
ACB   0.91 (+2.26%)
F   4.83 (-3.98%)
NFLX   375.50 (+1.22%)
BAC   21.23 (-3.68%)
GILD   74.76 (-1.54%)
PRI   88.48 (-2.46%)
DIS   96.60 (-3.21%)
Log in

LON:COS - Collagen Solutions Share Price, Forecast & News

GBX 1.12
0.00 (0.00 %)
(As of 03/31/2020 04:00 PM ET)
Today's Range
1
Now: GBX 1.13
1.10
50-Day Range
1.13
MA: GBX 2.29
2.90
52-Week Range
1
Now: GBX 1.13
5.40
Volume223,381 shs
Average Volume293,832 shs
Market Capitalization£4.99 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Collagen Solutions plc sources, develops, manufactures, and supplies medical grade collagen components and biomaterials for use in research, regenerative medicines, medical devices, and in-vitro diagnostics in Europe, the Middle East, Africa, North America, and Asia. It offers collagen soluble collagen, collagen powders, fibrillars, collagen gels, freeze dried collagen, and other products for use in orthopaedic, sports medicine, dental, wound care, cardiovascular, general, plastic, and reconstructive surgeries, as well as 3D cell culture research; Bovine Pericardium is used in bio-prosthetic heart valves, dural closures, bone and dental membranes, and surgical buttressing applications; and BSE-free bovine biomaterials. The company also provides product development and contract manufacturing services, including technology transfer and regulatory support services for collagen-based products. It serves pharmaceutical and medical device companies. Collagen Solutions plc was incorporated in 2013 and is based in London, the United Kingdom.
Read More

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-141-6489100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£4.43 million
Cash FlowGBX 1.30 per share
Book ValueGBX 5.10 per share

Profitability

Miscellaneous

Employees48
Market Cap£4.99 million
Next Earnings DateN/A
OptionableNot Optionable

Receive COS News and Ratings via Email

Sign-up to receive the latest news and ratings for COS and its competitors with MarketBeat's FREE daily newsletter.


Collagen Solutions (LON:COS) Frequently Asked Questions

How has Collagen Solutions' stock been impacted by COVID-19 (Coronavirus)?

Collagen Solutions' stock was trading at GBX 2.20 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, COS stock has decreased by 48.9% and is now trading at GBX 1.13. View which stocks have been mosted impacted by Coronavirus.

Has Collagen Solutions been receiving favorable news coverage?

News headlines about COS stock have trended positive this week, InfoTrie reports. InfoTrie scores the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Collagen Solutions earned a daily sentiment score of 3.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutCollagen Solutions.

Who are some of Collagen Solutions' key competitors?

What other stocks do shareholders of Collagen Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Collagen Solutions investors own include ReNeuron Group (RENE), Sareum (SAR), Oxford BioMedica (OXB), ValiRx (VAL), Active Energy Group (AEG), Norcros (NXR), Proteome Sciences (PRM), Oxford Instruments (OXIG), Perseus Mining (PRU) and Parity Group (PTY).

Who are Collagen Solutions' key executives?

Collagen Solutions' management team includes the following people:
  • Mr. Jamal D. Rushdy, CEO & Director (Age 47)
  • Ms. Hilary G. Spence, CFO & Director
  • Ms. Gillian Nancy Black, Company Sec. & VP of Global Fin. (Age 56)
  • Dr. Stewart White Ph.D., MBA, Consultant & Member of Scientific Advisory Board (Age 48)
  • Mr. Tom Hyland, COO, Director & Member of Scientific Advisory Board (Age 53)

What is Collagen Solutions' stock symbol?

Collagen Solutions trades on the London Stock Exchange (LON) under the ticker symbol "COS."

How do I buy shares of Collagen Solutions?

Shares of COS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Collagen Solutions' stock price today?

One share of COS stock can currently be purchased for approximately GBX 1.13.

How big of a company is Collagen Solutions?

Collagen Solutions has a market capitalization of £4.99 million and generates £4.43 million in revenue each year. Collagen Solutions employs 48 workers across the globe. View additional information about Collagen Solutions.

What is Collagen Solutions' official website?

The official website for Collagen Solutions is http://www.collagensolutions.com/.

How can I contact Collagen Solutions?

Collagen Solutions' mailing address is Nova Business Park, 3 Robroyston Oval, GLASGOW, G33 1AP, United Kingdom. The company can be reached via phone at +44-141-6489100.


MarketBeat Community Rating for Collagen Solutions (LON COS)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  129 (Vote Outperform)
Underperform Votes:  97 (Vote Underperform)
Total Votes:  226
MarketBeat's community ratings are surveys of what our community members think about Collagen Solutions and other stocks. Vote "Outperform" if you believe COS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe COS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel